A Multicenter Randomized Controlled Trial to Evaluate the Effect of Adjuvant Chemotherapy using Gemcitabine After Resection of Pancreatic Cancer
Phase 3
- Conditions
- resectable pancreatic cancer
- Registration Number
- JPRN-C000000037
- Lead Sponsor
- Study Group for Adjuvant Chemotherapy of Pancreatic Cancer
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
interstitial pneumonia, pulmonary fibrosis intractable pleural effusion distant metastasis other active cancers apparent infection sever postoperative complications active peptic ulcer episode of myocardial infarction within three months mental disorders pregnacy or patient's hope to be pregnant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method survival time, recurrence rate
- Secondary Outcome Measures
Name Time Method adverse effect